טוען...
Use and Spending on Biologic Disease-modifying Anti-rheumatic Drugs for Rheumatoid Arthritis among U.S. Medicare Beneficiaries
OBJECTIVES: Biologic therapies have assumed an important role in treating rheumatoid arthritis (RA). We sought to investigate use, spending, and patient cost-sharing for Medicare beneficiaries using biologic drugs for RA, comparing patients exposed to minimal cost-sharing because of a Part D low-inc...
שמור ב:
| הוצא לאור ב: | Arthritis Care Res (Hoboken) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4573380/ https://ncbi.nlm.nih.gov/pubmed/25776035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22580 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|